- Home
- NKLA vs SCPH Comparison
NKLA vs SCPH Comparison
Compare NKLA & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKLA
- SCPH
- Stock Information
- Founded
- NKLA 2015
- SCPH 2013
- Country
- NKLA United States
- SCPH United States
- Employees
- NKLA N/A
- SCPH N/A
- Industry
- NKLA Auto Manufacturing
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NKLA Consumer Discretionary
- SCPH Health Care
- Exchange
- NKLA Nasdaq
- SCPH Nasdaq
- Market Cap
- NKLA 273.2M
- SCPH 274.7M
- IPO Year
- NKLA N/A
- SCPH 2017
- Fundamental
- Price
- NKLA $1.67
- SCPH $3.60
- Analyst Decision
- NKLA Hold
- SCPH Strong Buy
- Analyst Count
- NKLA 4
- SCPH 2
- Target Price
- NKLA $6.00
- SCPH $15.00
- AVG Volume (30 Days)
- NKLA 7.2M
- SCPH 573.6K
- Earning Date
- NKLA 10-31-2024
- SCPH 11-13-2024
- Dividend Yield
- NKLA N/A
- SCPH N/A
- EPS Growth
- NKLA N/A
- SCPH N/A
- EPS
- NKLA N/A
- SCPH N/A
- Revenue
- NKLA $75,529,000.00
- SCPH $30,278,000.00
- Revenue This Year
- NKLA $215.24
- SCPH $174.12
- Revenue Next Year
- NKLA $200.04
- SCPH $133.41
- P/E Ratio
- NKLA N/A
- SCPH N/A
- Revenue Growth
- NKLA 153.71
- SCPH 303.87
- 52 Week Low
- NKLA $1.64
- SCPH $3.08
- 52 Week High
- NKLA $34.50
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- NKLA 25.57
- SCPH 43.65
- Support Level
- NKLA $1.89
- SCPH $3.30
- Resistance Level
- NKLA $2.04
- SCPH $3.82
- Average True Range (ATR)
- NKLA 0.26
- SCPH 0.28
- MACD
- NKLA 0.01
- SCPH 0.04
- Stochastic Oscillator
- NKLA 1.85
- SCPH 56.15
About NKLA Nikola Corporation
Nikola Corp is a technology innovator and integrator, working to develop inventive energy and transportation solutions. It works on a business model that enables customers and fleets to integrate next-generation truck technology, hydrogen fueling and charging infrastructure, and related maintenance. It operates in two business units: Truck and Energy. The Truck business unit and Energy business unit. The Truck business unit is engaged manufacturing and selling FCEV and BEV trucks that provide, environmentally friendly, cost effective solutions to the trucking sector. The Energy business unit is engaged in developing and constructing a network of hydrogen fueling stations to meet hydrogen fuel demand for the Company's customers.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.